Cofactoring and Dimerization of Proteinase-Activated Receptors
暂无分享,去创建一个
[1] J. Trejo,et al. Transactivation of the PAR1-PAR2 Heterodimer by Thrombin Elicits β-Arrestin-mediated Endosomal Signaling* , 2013, The Journal of Biological Chemistry.
[2] D. Kirchhofer,et al. PAR-1 contributes to the innate immune response during viral infection. , 2013, The Journal of clinical investigation.
[3] A. Arachiche,et al. Calcium Mobilization And Protein Kinase C Activation Downstream Of Protease Activated Receptor 4 (PAR4) Is Negatively Regulated By PAR3 In Mouse Platelets , 2013, PloS one.
[4] Jianyun Huang,et al. Crystal Structure of Oligomeric β1-Adrenergic G Protein- Coupled Receptors in Ligand-Free Basal State , 2013, Nature Structural &Molecular Biology.
[5] J. Griffin,et al. Biased agonism of protease-activated receptor 1 by activated protein C caused by noncanonical cleavage at Arg46. , 2012, Blood.
[6] R. Gainetdinov,et al. BRET biosensors to study GPCR biology, pharmacology, and signal transduction , 2012, Front. Endocrin..
[7] C. Pagel,et al. Evaluation of antibodies directed against human protease-activated receptor-2 , 2012, Naunyn-Schmiedeberg's Archives of Pharmacology.
[8] S. Nuber,et al. Fluorescence/Bioluminescence Resonance Energy Transfer Techniques to Study G-Protein-Coupled Receptor Activation and Signaling , 2012, Pharmacological Reviews.
[9] L. Pardo,et al. Crystal structure of the μ-opioid receptor bound to a morphinan antagonist , 2012, Nature.
[10] S. Mundell,et al. Novel Role for Proteinase-activated Receptor 2 (PAR2) in Membrane Trafficking of Proteinase-activated Receptor 4 (PAR4)* , 2012, The Journal of Biological Chemistry.
[11] Bryan L. Roth,et al. Structure of the human kappa opioid receptor in complex with JDTic , 2012, Nature.
[12] M. Nieman,et al. Mapping Human Protease-activated Receptor 4 (PAR4) Homodimer Interface to Transmembrane Helix 4* , 2012, The Journal of Biological Chemistry.
[13] C. Esmon,et al. Cytoprotective signaling by activated protein C requires protease-activated receptor-3 in podocytes. , 2012, Blood.
[14] M. Hollenberg,et al. Targeting proteinase-activated receptors: therapeutic potential and challenges , 2012, Nature Reviews Drug Discovery.
[15] J. Trejo,et al. Activated protein C promotes protease-activated receptor-1 cytoprotective signaling through β-arrestin and dishevelled-2 scaffolds , 2011, Proceedings of the National Academy of Sciences.
[16] A. Kuliopulos,et al. Matrix metalloproteases and PAR1 activation. , 2011, Blood.
[17] Michael R Dores,et al. Adaptor Protein Complex-2 (AP-2) and Epsin-1 Mediate Protease-activated Receptor-1 Internalization via Phosphorylation- and Ubiquitination-dependent Sorting Signals* , 2011, The Journal of Biological Chemistry.
[18] A. Bohm,et al. Interdicting protease-activated receptor-2-driven inflammation with cell-penetrating pepducins , 2011, Proceedings of the National Academy of Sciences.
[19] R. Abagyan,et al. Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists , 2010, Science.
[20] S. Sligar,et al. Monomeric Rhodopsin Is Sufficient for Normal Rhodopsin Kinase (GRK1) Phosphorylation and Arrestin-1 Binding* , 2010, The Journal of Biological Chemistry.
[21] J. Javitch,et al. Time-resolved FRET between GPCR ligands reveals oligomers in native tissues. , 2010, Nature chemical biology.
[22] Michael R Dores,et al. Signal transduction by protease‐activated receptors , 2010, British journal of pharmacology.
[23] C. Craik,et al. Local protease signaling contributes to neural tube closure in the mouse embryo. , 2010, Developmental cell.
[24] J. Trejo,et al. Phosphorylation of Protease-activated Receptor-2 Differentially Regulates Desensitization and Internalization* , 2009, The Journal of Biological Chemistry.
[25] N. Lambert,et al. Instability of a Class A G Protein-Coupled Receptor Oligomer Interface , 2009, Molecular Pharmacology.
[26] J. Trejo,et al. Caveolae are required for protease-selective signaling by protease-activated receptor–1 , 2009, Proceedings of the National Academy of Sciences.
[27] Stefan Engelhardt,et al. Analysis of receptor oligomerization by FRAP microscopy , 2009, Nature Methods.
[28] S. Marullo,et al. An escort for GPCRs: implications for regulation of receptor density at the cell surface. , 2008, Trends in pharmacological sciences.
[29] N. Tinel,et al. Cell-surface protein-protein interaction analysis with time-resolved FRET and snap-tag technologies: application to GPCR oligomerization , 2008, Nature Methods.
[30] J. Bockaert,et al. Subcellular imaging of dynamic protein interactions by bioluminescence resonance energy transfer. , 2008, Biophysical journal.
[31] C. Derian,et al. 'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage , 2007, Nature Immunology.
[32] A. Malik,et al. Dual Regulation of Endothelial Junctional Permeability , 2007, Science's STKE.
[33] E. Di Cera,et al. Crystal structures of murine thrombin in complex with the extracellular fragments of murine protease-activated receptors PAR3 and PAR4 , 2007, Proceedings of the National Academy of Sciences.
[34] Richard N. Zare,et al. A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein , 2007, Proceedings of the National Academy of Sciences.
[35] J. Griffin,et al. The cytoprotective protein C pathway. , 2007 .
[36] A. Malik,et al. Protease-activated receptor-3 (PAR3) regulates PAR1 signaling by receptor dimerization , 2007, Proceedings of the National Academy of Sciences.
[37] J. Trejo,et al. Protease-activated receptor signalling, endocytic sorting and dysregulation in cancer , 2007, Journal of Cell Science.
[38] W. Thomas,et al. Extended bioluminescence resonance energy transfer (eBRET) for monitoring prolonged protein-protein interactions in live cells. , 2006, Cellular signalling.
[39] H. Hamm,et al. PAR4, but Not PAR1, Signals Human Platelet Aggregation via Ca2+ Mobilization and Synergistic P2Y12 Receptor Activation* , 2006, Journal of Biological Chemistry.
[40] D. Siderovski,et al. Clathrin Adaptor AP2 Regulates Thrombin Receptor Constitutive Internalization and Endothelial Cell Resensitization , 2006, Molecular and Cellular Biology.
[41] C. Derian,et al. Blocking the Protease-Activated Receptor 1-4 Heterodimer in Platelet-Mediated Thrombosis , 2006, Circulation.
[42] F. Hamdan,et al. Monitoring Protein‐Protein Interactions in Living Cells by Bioluminescence Resonance Energy Transfer (BRET) , 2006, Current protocols in neuroscience.
[43] A. Samarel,et al. A role for proteinase-activated receptor 2 and PKC-epsilon in thrombin-mediated induction of decay-accelerating factor on human endothelial cells. , 2005, American journal of physiology. Cell physiology.
[44] C. Feistritzer,et al. Protease‐activated receptors‐1 and ‐2 can mediate endothelial barrier protection: role in factor Xa signaling , 2005, Journal of thrombosis and haemostasis : JTH.
[45] S. Coughlin,et al. Protease‐activated receptors in hemostasis, thrombosis and vascular biology , 2005, Journal of thrombosis and haemostasis : JTH.
[46] Michel Bouvier,et al. Bioluminescence Resonance Energy Transfer Reveals Ligand-induced Conformational Changes in CXCR4 Homo- and Heterodimers* , 2005, Journal of Biological Chemistry.
[47] J. Trejo,et al. Multiple Independent Functions of Arrestins in the Regulation of Protease-Activated Receptor-2 Signaling and Trafficking , 2005, Molecular Pharmacology.
[48] Michel Bouvier,et al. Real-time monitoring of ubiquitination in living cells by BRET , 2004, Nature Methods.
[49] Jean-François Mercier,et al. Homodimerization of the β2-Adrenergic Receptor as a Prerequisite for Cell Surface Targeting* , 2004, Journal of Biological Chemistry.
[50] L. Brass,et al. Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis. , 2004, Molecular cancer research : MCR.
[51] J. Trejo,et al. Termination of Protease-activated Receptor-1 Signaling by β-Arrestins Is Independent of Receptor Phosphorylation* , 2004, Journal of Biological Chemistry.
[52] K. Fuxe,et al. Homodimerization of adenosine A2A receptors: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer , 2003, Journal of neurochemistry.
[53] S. Schulz,et al. Heterodimerization of Substance P and μ-Opioid Receptors Regulates Receptor Trafficking and Resensitization* , 2003, Journal of Biological Chemistry.
[54] A. Kuliopulos,et al. Protease-activated receptor-4 uses dual prolines and an anionic retention motif for thrombin recognition and cleavage. , 2003, The Biochemical journal.
[55] Francesca Fanelli,et al. Adenosine A2A-Dopamine D2 Receptor-Receptor Heteromerization , 2003, Journal of Biological Chemistry.
[56] J. Baleja,et al. Structural basis for thrombin activation of a protease-activated receptor: inhibition of intramolecular liganding. , 2003, Chemistry & biology.
[57] M. Simon,et al. G13 is an essential mediator of platelet activation in hemostasis and thrombosis , 2003, Nature Medicine.
[58] L. Prézeau,et al. Evolution, structure, and activation mechanism of family 3/C G-protein-coupled receptors. , 2003, Pharmacology & therapeutics.
[59] R. Hotchkiss,et al. The pathophysiology and treatment of sepsis. , 2003, The New England journal of medicine.
[60] P. Fossier,et al. Monitoring of Ligand-independent Dimerization and Ligand-induced Conformational Changes of Melatonin Receptors in Living Cells by Bioluminescence Resonance Energy Transfer* 210 , 2002, The Journal of Biological Chemistry.
[61] Wei Huang,et al. Role of thrombin signalling in platelets in haemostasis and thrombosis , 2001, Nature.
[62] S. Coughlin,et al. A Role for Thrombin Receptor Signaling in Endothelial Cells During Embryonic Development , 2001, Science.
[63] Michel Bouvier,et al. Oligomerization of G-protein-coupled transmitter receptors , 2001, Nature Reviews Neuroscience.
[64] L. Brass,et al. Protease activated receptors: theme and variations , 2001, Oncogene.
[65] M. LeMasurier,et al. Substrate-Assisted Catalysis of the PAR1 Thrombin Receptor , 2000, The Journal of Biological Chemistry.
[66] S. Coughlin,et al. Protease-activated Receptors 1 and 4 Are Shut Off with Distinct Kinetics after Activation by Thrombin* , 2000, The Journal of Biological Chemistry.
[67] N. Prévost,et al. Thrombin Responses in Human Endothelial Cells , 2000, The Journal of Biological Chemistry.
[68] A. Kuliopulos,et al. Biphasic kinetics of activation and signaling for PAR1 and PAR4 thrombin receptors in platelets. , 2000, Biochemistry.
[69] S. Coughlin,et al. PAR3 is a cofactor for PAR4 activation by thrombin , 2000, Nature.
[70] R. Mullins,et al. β-Arrestin–Dependent Endocytosis of Proteinase-Activated Receptor 2 Is Required for Intracellular Targeting of Activated Erk1/2 , 2000, The Journal of cell biology.
[71] S. Coughlin,et al. How the protease thrombin talks to cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[72] S. Coughlin,et al. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. , 1999, The Journal of clinical investigation.
[73] Robert V Farese,et al. A dual thrombin receptor system for platelet activation , 1998, Nature.
[74] Scott R. Presnell,et al. Cloning and characterization of human protease-activated receptor 4. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[75] S. Coughlin,et al. Protease-activated receptor 3 is a second thrombin receptor in humans , 1997, Nature.
[76] J. Hoxie,et al. Interactions of Mast Cell Tryptase with Thrombin Receptors and PAR-2* , 1997, The Journal of Biological Chemistry.
[77] S. Coughlin,et al. Role of the Thrombin Receptor's Cytoplasmic Tail in Intracellular Trafficking , 1996, The Journal of Biological Chemistry.
[78] R. Scarborough,et al. Ligand Cross-reactivity within the Protease-activated Receptor Family* , 1996, The Journal of Biological Chemistry.
[79] J. Pouysségur,et al. Post-translational and Activation-dependent Modifications of the G Protein-coupled Thrombin Receptor (*) , 1995, The Journal of Biological Chemistry.
[80] S. Coughlin. Protease-activated receptors start a family. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[81] C. Wahlestedt,et al. Molecular cloning of a potential proteinase activated receptor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[82] J. Chen,et al. Thrombin receptor activation. Confirmation of the intramolecular tethered liganding hypothesis and discovery of an alternative intermolecular liganding mode. , 1994, The Journal of biological chemistry.
[83] Paul R. Selvin,et al. Luminescence resonance energy transfer , 1994 .
[84] P. Dennington,et al. THE THROMBIN RECEPTOR , 1994, Clinical and experimental pharmacology & physiology.
[85] V. Wheaton,et al. Tethered ligand agonist peptides. Structural requirements for thrombin receptor activation reveal mechanism of proteolytic unmasking of agonist function. , 1992, The Journal of biological chemistry.
[86] V. Wheaton,et al. Domains specifying thrombin–receptor interaction , 1991, Nature.
[87] V. Wheaton,et al. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation , 1991, Cell.
[88] R. Huber,et al. The structure of a complex of recombinant hirudin and human alpha-thrombin. , 1990, Science.
[89] Jason M. Conley,et al. Bimolecular fluorescence complementation analysis of G protein-coupled receptor dimerization in living cells. , 2013, Methods in enzymology.
[90] R. Stevens,et al. Structure of the human k-opioid receptor in complex with JDTic , 2012 .
[91] L. Devi,et al. Exploring a role for heteromerization in GPCR signalling specificity. , 2011, The Biochemical journal.
[92] H. Hamm,et al. Heterotrimeric G protein activation by G-protein-coupled receptors , 2008, Nature Reviews Molecular Cell Biology.
[93] R. Buser,et al. Calcium mobilization. , 2000, Methods in molecular biology.
[94] N. Prévost,et al. Thrombin Responses in Human Endothelial Cells CONTRIBUTIONS FROM RECEPTORS OTHER THAN PAR1 INCLUDE THE TRANSACTIVATION OF PAR2 BY THROMBIN-CLEAVED PAR1* , 2000 .
[95] S. Coughlin,et al. Antibodies to protease-activated receptor 3 inhibit activation of mouse platelets by thrombin. , 1998, Blood.
[96] M. Simon,et al. Defective platelet activation in G alpha(q)-deficient mice. , 1997, Nature.
[97] C. A. Thomas,et al. Molecular cloning. , 1977, Advances in pathobiology.